Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor.
K M Argraves, … , P C Harpel, D K Strickland
K M Argraves, … , P C Harpel, D K Strickland
Published November 1, 1997
Citation Information: J Clin Invest. 1997;100(9):2170-2181. https://doi.org/10.1172/JCI119753.
View: Text | PDF
Research Article Article has an altmetric score of 3

The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor.

  • Text
  • PDF
Abstract

Research Article

Authors

K M Argraves, K F Kozarsky, J T Fallon, P C Harpel, D K Strickland

×

Total citations by year

Year: 2025 2024 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 Total
Citations: 3 5 1 3 6 4 7 11 4 8 3 3 3 5 2 3 1 1 1 5 4 6 1 7 5 10 7 119
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2011 (5)

Title and authors Publication Year
A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis
PS Bhattacharjee, TS Huq, TK Mandal, RA Graves, S Muniruzzaman, C Clement, HE McFerrin, JM Hill
PloS one 2011
Abnormal Lipoprotein(a) Levels Predict Coronary Artery Calcification in Southeast Asians but Not in Caucasians: Use of Noninvasive Imaging for Evaluation of an Emerging Risk Factor
A Sharma, M Kasim, PH Joshi, Z Qian, E Krivitsky, K Akram, S Rinehart, G Vazquez, J Miller, MS Rohman, S Voros
Journal of Cardiovascular Translational Research 2011
Species differences of macrophage very low-density-lipoprotein (VLDL) receptor protein expression
S Takahashi, T Ito, Y Zenimaru, J Suzuki, I Miyamori, M Takahashi, M Takahashi, T Ishida, T Ishida, K Hirata, TT Yamamoto, T Iwasaki, H Hattori, M Shiomi
Biochemical and Biophysical Research Communications 2011
Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism
M Konerman, K Kulkarni, PP Toth, SR Jones
Journal of Clinical Lipidology 2011
A Novel Peptide Derived from Human Apolipoprotein E Is an Inhibitor of Tumor Growth and Ocular Angiogenesis
PS Bhattacharjee, TS Huq, TK Mandal, RA Graves, S Muniruzzaman, C Clement, HE McFerrin, JM Hill, A Lewin
PloS one 2011

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
57 readers on Mendeley
See more details